After receiving a dysautonomia diagnosis, many patients begin researching their condition and stumble upon references to autoimmune connections. This naturally raises questions: Is my dysautonomia caused by my immune system? Am I dealing with an autoimmune disease? Will I need immunotherapy?
The relationship between dysautonomia and autoimmunity is complex and still being actively researched. While not all dysautonomia is autoimmune, growing evidence suggests that immune system dysfunction plays a significant role in many cases—particularly those developing after infections.
Let’s explore what we know about the autoimmune aspects of dysautonomia, how to identify if your condition has an immune component, and what this means for treatment.
Understanding Autoimmune Disorders
Before examining dysautonomia’s autoimmune connections, let’s clarify what “autoimmune” actually means.
In autoimmune disorders, the immune system—which normally protects you from infections and diseases—mistakenly attacks your own body’s tissues. Instead of recognizing “self” as safe, the immune system produces antibodies or immune cells that target your own organs, tissues, or cells.
Common autoimmune disorders include:
- Type 1 diabetes (immune system attacks insulin-producing cells)
- Rheumatoid arthritis (attacks joints)
- Lupus (attacks multiple organs)
- Celiac disease (attacks intestinal lining in response to gluten)
- Multiple sclerosis (attacks nervous system myelin)
- Sjögren’s syndrome (attacks moisture-producing glands)
These conditions cause inflammation and tissue damage in the targeted areas, leading to dysfunction and symptoms.
Is All Dysautonomia Autoimmune?
The short answer: No, not all dysautonomia is autoimmune.
Dysautonomia is an umbrella term covering many conditions with diverse causes. While some forms clearly involve autoimmune mechanisms, others result from different processes entirely.
Three Categories:
Definitely Autoimmune: Conditions where antibodies or immune cells attacking the autonomic nervous system have been clearly identified.
Possibly Autoimmune: Conditions with strong circumstantial evidence of immune involvement but where specific antibodies or mechanisms aren’t yet fully proven.
Not Autoimmune: Dysautonomia caused by physical damage, genetic conditions, or other non-immune mechanisms.
Understanding types of dysautonomia with autoimmune origins helps clarify which conditions fall into each category.
Types of Dysautonomia with Confirmed Autoimmune Mechanisms
Several dysautonomia conditions have clear autoimmune origins:
Autoimmune Autonomic Ganglionopathy (AAG)
This rare but well-characterized autoimmune condition involves antibodies attacking autonomic ganglia—clusters of nerve cell bodies that relay signals in the autonomic nervous system.
Key Features:
- Rapid onset of widespread autonomic failure
- Antibodies against ganglionic acetylcholine receptors detected in blood
- Affects multiple autonomic functions (blood pressure, digestion, bladder, sweating)
- Can be severe, causing profound orthostatic hypotension and widespread dysfunction
- Often responds to immunotherapy (intravenous immunoglobulin, plasmapheresis, or immunosuppressants)
AAG represents the clearest example of autoimmune dysautonomia—the cause is known, antibodies can be measured, and immune-targeted treatment often helps.
Autoimmune Autonomic Neuropathy
Beyond AAG, other antibodies can attack various components of the autonomic nervous system:
Antibodies Against Autonomic Receptors:
- Alpha and beta-adrenergic receptor antibodies
- Muscarinic receptor antibodies
- Other receptor-targeting antibodies
These antibodies can interfere with normal autonomic signaling, causing dysfunction without necessarily destroying nerve tissue.
Dysautonomia Associated with Other Autoimmune Diseases
Many established autoimmune conditions can cause secondary dysautonomia:
Sjögren’s Syndrome: This autoimmune disorder attacking moisture-producing glands frequently causes autonomic neuropathy affecting multiple systems.
Lupus (SLE): Can cause autonomic dysfunction through various mechanisms including inflammation of autonomic nerves or blood vessel inflammation affecting circulation.
Celiac Disease: May cause autonomic neuropathy, possibly improving with strict gluten-free diet.
Guillain-Barré Syndrome: Acute autoimmune attack on peripheral nerves that can include autonomic nerve involvement.
In these cases, treating the underlying autoimmune disease may improve dysautonomia symptoms, though autonomic dysfunction can sometimes persist even when the primary condition is controlled.
Post-Viral Dysautonomia and Immune System Dysfunction
One of the most common triggers for dysautonomia—particularly POTS—is viral infection. The mechanism likely involves immune system activation that doesn’t properly “turn off” after the infection resolves.
How Infections Trigger Immune-Mediated Dysautonomia:
Molecular Mimicry: Viral proteins resemble human proteins. Antibodies made to fight the virus accidentally cross-react with parts of the autonomic nervous system.
Persistent Immune Activation: The immune system remains activated long after the virus clears, causing ongoing inflammation affecting autonomic nerves.
Autoantibody Production: Some patients develop antibodies against autonomic receptors or nerve components after infections.
Inflammatory Damage: Even without specific autoantibodies, widespread inflammation from fighting infection can damage small autonomic nerve fibers.
Post-viral dysautonomia and immune system dysfunction explains why many POTS patients can trace symptom onset to a specific infection—mononucleosis, flu, COVID-19, or other viral illnesses.
Why Some Patients Develop POTS After Infections
Why some patients develop POTS after infections relates to individual immune responses and genetic predispositions.
Not everyone who gets sick develops lasting dysautonomia. Several factors may determine who develops post-infectious dysautonomia:
Genetic Susceptibility:
Certain genetic variants affecting immune function may predispose some individuals to developing autoimmune or post-viral conditions. Having family members with autoimmune diseases increases risk.
Prior Immune System Priming:
Previous infections or exposures may “prime” the immune system, making it more likely to overreact to subsequent infections.
Severity of Initial Illness:
More severe acute infections may cause greater immune system activation and subsequent dysregulation.
Individual Immune System Characteristics:
Some people naturally produce more autoantibodies or have more reactive immune systems, increasing risk of post-infectious autoimmune conditions.
Long COVID’s Autoimmune Connection to POTS
The COVID-19 pandemic revealed a dramatic increase in post-viral dysautonomia, bringing renewed attention to immune mechanisms.
Long COVID’s autoimmune connection to POTS has become a major research focus:
Evidence of Immune Involvement in Long COVID POTS:
Autoantibodies Detected: Studies have found various autoantibodies in long COVID patients with POTS-like symptoms:
- Antibodies against adrenergic receptors (affecting blood vessel constriction and heart rate)
- Antibodies against muscarinic receptors (affecting parasympathetic nervous system)
- Antibodies against other autonomic nervous system components
Inflammatory Markers: Many long COVID patients show persistent elevation of inflammatory markers suggesting ongoing immune activation.
Response to Immunotherapy: Some long COVID patients with severe POTS symptoms show improvement with immunomodulating treatments, suggesting immune mechanisms.
Small Fiber Neuropathy: Skin biopsies in some long COVID patients reveal reduced small nerve fiber density, consistent with immune-mediated nerve damage.
While not all long COVID POTS is autoimmune, immune dysregulation appears to play a role in a substantial subset of patients.
Testing for Autoimmune Dysautonomia
If you suspect your dysautonomia has an autoimmune component, specific testing can provide answers—though not all autoimmune mechanisms can currently be detected.
Available Tests:
Ganglionic Acetylcholine Receptor Antibodies: The most established test, detects AAG. Available at specialized labs.
Adrenergic and Muscarinic Receptor Antibodies: Research labs can test for these, though availability varies and clinical interpretation is still evolving.
General Autoimmune Markers:
- ANA (antinuclear antibodies) – screens for general autoimmunity
- Rheumatoid factor
- Inflammatory markers (ESR, CRP)
- Complement levels
Tests for Specific Autoimmune Diseases: If symptoms suggest a particular autoimmune condition, targeted testing for that disease.
Small Fiber Neuropathy Testing: Skin biopsy can detect autonomic nerve fiber loss, though it can’t distinguish between autoimmune and other causes.
Important Limitations:
Many patients with likely autoimmune dysautonomia test negative for known antibodies. This doesn’t mean autoimmunity isn’t involved—it may mean:
- Their specific antibody hasn’t been identified yet
- Current tests aren’t sensitive enough
- The immune mechanism doesn’t involve antibodies detectable in blood
- The autoimmune process has resolved but damage persists
Medical research continues identifying new autoantibodies and mechanisms. A negative test today doesn’t rule out immune involvement.
Neurological Autoimmune Overlap
Understanding neurological autoimmune overlap helps explain how immune system attacks on the nervous system manifest as dysautonomia.
The autonomic nervous system is part of the peripheral nervous system. When autoantibodies or immune cells attack peripheral nerves, they may preferentially damage:
Only autonomic fibers (causing pure dysautonomia) Both autonomic and somatic fibers (causing dysautonomia plus numbness, tingling, or weakness) Autonomic ganglia or receptors (interfering with signal transmission)
This explains why some autoimmune neuropathies cause primarily autonomic symptoms while others affect multiple nerve types.
The blood-nerve barrier—similar to the blood-brain barrier—normally protects nerves from immune attack. In autoimmune conditions, this barrier becomes compromised, allowing antibodies and immune cells access to nerve tissue.
Treatment Implications of Autoimmune Dysautonomia
Identifying an autoimmune component to dysautonomia can significantly change treatment approaches:
For Confirmed Autoimmune Dysautonomia (AAG):
Immunotherapy Options:
- Intravenous Immunoglobulin (IVIG): Provides antibodies that may neutralize harmful autoantibodies
- Plasmapheresis: Filters antibodies from blood
- Immunosuppressants: Medications like azathioprine, mycophenolate, or rituximab that dampen immune system activity
- Corticosteroids: Reduce immune system activation and inflammation
These treatments target the underlying immune dysfunction rather than just managing symptoms. Response rates vary, with some patients showing dramatic improvement.
For Suspected Autoimmune or Post-Viral Dysautonomia:
Treatment becomes more nuanced when clear autoantibodies aren’t identified but immune involvement seems likely:
Conservative Immune Modulation:
- Low-dose naltrexone (may reduce inflammation and modulate immune function)
- Addressing inflammation through diet and lifestyle
- Managing stress (which affects immune function)
Symptomatic Treatment: Standard dysautonomia management (increased fluids and salt as directed by healthcare provider, compression garments, medications) alongside monitoring for signs that might warrant immunotherapy trial.
Time: Many post-viral dysautonomia cases improve gradually over 6-24 months as the immune system settles and inflammation resolves, even without specific immunotherapy.
When to Consider Immunotherapy:
Immunotherapy carries risks and isn’t appropriate for everyone. Consider discussing it with your specialist if:
- Severe, rapidly progressing symptoms
- Positive autoantibody testing
- Dysautonomia alongside other autoimmune conditions
- Failure of standard treatment approaches
- Evidence of ongoing inflammation
The Role of Inflammation
Even without specific autoantibodies, inflammation plays a role in many dysautonomia cases:
Chronic Low-Grade Inflammation: Can damage small nerve fibers over time, contributing to autonomic dysfunction.
Mast Cell Activation: Some dysautonomia patients have mast cell activation syndrome, where immune cells release excessive inflammatory mediators. This creates inflammation affecting autonomic function.
Cytokine Dysregulation: Imbalanced inflammatory signaling molecules can affect autonomic nervous system function even without true autoimmunity.
Anti-inflammatory approaches—whether through diet, supplements, or medications—may help these patients even if classic autoimmune treatments aren’t warranted.
Autoimmune Dysautonomia vs. POTS
It’s important to note that POTS is a clinical syndrome—a constellation of symptoms and signs—rather than a specific disease with one cause.
POTS can result from:
- Autoimmune mechanisms (autoantibodies, post-viral immune dysfunction)
- Neuropathy (autoimmune or non-autoimmune)
- Hypovolemia (low blood volume)
- Deconditioning
- Hyperadrenergic state (excess adrenaline)
- Connective tissue disorders like EDS
In many patients, multiple mechanisms contribute. Someone might have POTS from both post-viral immune dysfunction and deconditioning, for example.
This is why comprehensive evaluation by a POTS specialist in Maryland or dysautonomia specialist is so important—they can identify which mechanisms are active in your specific case, including whether autoimmune factors play a role.
Living with Possible Autoimmune Dysautonomia
If you suspect your dysautonomia has an autoimmune component, several strategies can help:
Document Your History:
- Record when symptoms started
- Note any preceding infections, illnesses, or triggers
- Track family history of autoimmune diseases
- Keep records of any autoimmune test results
This information helps doctors assess likelihood of immune involvement.
Support Immune Health:
While you can’t control autoimmune processes directly, supporting overall immune health may help:
- Adequate sleep (crucial for immune regulation)
- Stress management (chronic stress worsens immune dysregulation)
- Balanced nutrition (nutrient deficiencies can worsen autoimmune activity)
- Avoiding smoking and excessive alcohol
- Regular but not excessive exercise (overexertion can trigger immune flares)
Monitor for Associated Conditions:
People with one autoimmune condition have higher risk of developing others. Watch for symptoms suggesting:
- Thyroid dysfunction
- Rheumatoid arthritis
- Lupus
- Sjögren’s syndrome
- Celiac disease
Early detection and treatment of associated autoimmune conditions may help overall symptom management.
Stay Informed:
Research on autoimmune dysautonomia is rapidly evolving. New antibodies are being discovered, and new treatment approaches are being tested. Staying connected with dysautonomia organizations and research updates helps you remain informed about new developments.
The Future of Autoimmune Dysautonomia Research
Exciting research directions include:
Antibody Discovery: Ongoing work identifying new autoantibodies associated with dysautonomia.
Biomarker Development: Finding markers that predict which post-viral patients will develop chronic dysautonomia.
Targeted Therapies: Developing treatments that specifically neutralize harmful antibodies while preserving normal immune function.
Understanding Mechanisms: Clarifying exactly how immune system dysfunction leads to autonomic symptoms, enabling more precise interventions.
Clinical Trials: Testing immunotherapies specifically in dysautonomia patients to establish evidence-based protocols.
As understanding deepens, treatment for autoimmune dysautonomia will likely become more targeted and effective.
Finding Specialized Care
If you suspect autoimmune mechanisms in your dysautonomia, seek care from providers familiar with both dysautonomia and autoimmunity:
A dysautonomia specialist in Maryland who understands immune mechanisms can:
- Order appropriate autoimmune testing
- Interpret results in context of your specific symptoms
- Coordinate with immunologists or rheumatologists when needed
- Develop treatment plans addressing both immune and autonomic dysfunction
- Monitor for development of associated autoimmune conditions
Don’t assume your dysautonomia is autoimmune without evaluation, but also don’t dismiss the possibility if your history suggests it—particularly if symptoms began after infection or you have other autoimmune conditions.
The Bottom Line
Is dysautonomia an autoimmune disorder? Sometimes yes, sometimes no, and sometimes probably.
Some dysautonomia clearly results from autoimmune mechanisms, with identifiable antibodies and response to immunotherapy. Other cases have no autoimmune component. And many fall in the middle—suspected immune involvement without definitive proof.
The key takeaway: Autoimmunity represents one important mechanism underlying dysautonomia in many patients, particularly those with post-viral onset. Understanding whether your condition has an autoimmune component can guide treatment decisions and help explain why standard approaches may or may not work for you.
If you’re struggling with dysautonomia, especially if it began after an infection, discuss autoimmune evaluation with a dysautonomia specialist. Even if testing doesn’t reveal specific antibodies, understanding the potential immune component can inform your treatment approach and improve your chances of finding relief.
